What is the lowest dose of losartan
Searched over 200M research papers
Summary
7 papers analyzed
These studies suggest the lowest effective dose of losartan for children is 0.75 mg/kg, while for adults, it varies based on the condition being treated, with some studies indicating effectiveness at 50 mg daily.
Not a yes or no question
To use the Consensus Meter, try asking a simple yes or no question
Research summarized with Copilot
Beta20 papers analyzed
Lowest Dose of Losartan: Insights from Research Studies
Introduction to Losartan Dosage
Losartan, an angiotensin II receptor blocker (ARB), is widely used to manage hypertension, heart failure, and certain kidney conditions. Determining the optimal dosage is crucial for maximizing therapeutic benefits while minimizing side effects. This article synthesizes findings from multiple studies to identify the lowest effective dose of losartan.
Losartan Dosage in Hypertensive Children
Dose-Response in Children Aged 6-16 Years
A study investigating the dose-response relationship of losartan in hypertensive children aged 6 to 16 years found that a starting dose of 0.75 mg/kg (up to a maximum of 50 mg) effectively reduced diastolic blood pressure (DBP) within three weeks. The study stratified patients by weight and administered doses ranging from 2.5 mg to 100 mg. Results indicated a dose-dependent reduction in DBP, with the lowest dose group (2.5/5.0 mg) showing a significant decrease in DBP by 6.0 mm Hg.
Dose-Response in Children Aged 6 Months to 6 Years
Another study focused on younger children (6 months to 6 years) assessed losartan dosages of 0.1 mg/kg, 0.3 mg/kg, and 0.7 mg/kg per day. The study found that even the lowest dose of 0.1 mg/kg per day resulted in clinically significant reductions in both systolic blood pressure (SBP) and DBP, although no clear dose-response relationship was established. This suggests that very low doses can still be effective in this age group.
Losartan Dosage in Heart Failure
High-Dose vs. Low-Dose in Heart Failure Patients
In patients with heart failure, a study compared the effects of high-dose (150 mg) versus low-dose (50 mg) losartan. The findings indicated that the higher dose significantly reduced the rate of death or hospital admission for heart failure compared to the lower dose. However, the study did not explore doses lower than 50 mg, which limits its relevance to identifying the absolute lowest effective dose.
Losartan Dosage in Kidney Conditions
Low-Dose Losartan in IgA Nephropathy
A study on normotensive patients with immunoglobulin A (IgA) nephropathy evaluated the effects of a low dose of losartan (12.5 mg/day). The results showed a significant reduction in proteinuria without affecting systemic blood pressure, indicating that even a low dose can be beneficial for renal protection.
Optimal Dose for Diabetic Nephropathy
Research on diabetic nephropathy patients suggested that a dose of 100 mg/day is optimal for reducing albuminuria and blood pressure. However, the study also found that a 50 mg/day dose was effective, though less so than the higher doses. This indicates that while 50 mg/day is effective, higher doses may offer additional benefits.
Pharmacokinetic Considerations
A pharmacokinetic review of losartan suggested that the commonly prescribed dose of 50 mg/day might be too low for achieving maximal therapeutic benefits. The review recommended considering higher doses, such as 100 mg/day, to improve clinical efficacy. However, this recommendation is based on achieving optimal outcomes rather than identifying the lowest effective dose.
Conclusion
The lowest effective dose of losartan varies depending on the condition being treated and the patient population. For hypertensive children, doses as low as 0.1 mg/kg per day have shown efficacy. In normotensive patients with IgA nephropathy, a dose of 12.5 mg/day effectively reduced proteinuria. While higher doses may offer additional benefits, these findings highlight that very low doses of losartan can still provide significant therapeutic effects.
Sources and full results
Most relevant research papers on this topic
